Compare Abeona Therapeutics Inc (ABEO) vs Dominion Energy Inc (D) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Dominion Energy Inc — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Dominion Energy Inc trades at $69.9 (market cap $60.92B). The key difference: Dominion Energy Inc is far larger — about 163.2× Abeona Therapeutics Inc's market cap, and Dominion Energy Inc pays a 3.86% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | D | |
|---|---|---|
Market Cap | $373.32M | $60.92B |
Sector | Health | Utilities |
52-Week High | $7.23 | $69.84 |
52-Week Low | $4.17 | $56.32 |
Enterprise Value | $228.22M | $113.32B |
Dividend Yield | — | 3.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Dominion Energy (D) trades at $69.84, up 0.13% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 16.93% net income margin and trades near the analyst consensus price target of $69.50. Recent news highlights a proposed $66.8 billion acquisition by NextEra Energy, positioning Dominion as a key player in AI infrastructure and data center power demand.
The outlook remains positive due to strategic positioning in renewable energy and data center growth, though regulatory approval risks for the merger and high debt levels pose challenges. Earnings momentum and institutional support provide upside potential, but investors should monitor merger developments and interest rate impacts on utility valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Dominion Energy Inc
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →
